CJC-1295 with DAC Peptide

Key Highlights

• Extended Half-Life via DAC Technology: Features Drug Affinity Complex (DAC), which binds to plasma albumin to extend the active half-life up to 6–8 days.

• Sustained GH & IGF-1 Elevation: Promotes a continuous, steady release of endogenous Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) without sharp peaks and drop-offs.

• Tissue Repair & Muscle Recovery: Accelerates muscle tissue regeneration, supports tendon/ligament repair, and aids post-workout recovery.

• Metabolic & Composition Optimization: Enhances fat oxidation, supports lean muscle mass retention, and improves overall metabolic rate.

Mechanism of Action

CJC-1295 with DAC acts as a potent synthetic analog of endogenous GHRH:

1. Pituitary Activation: Binds specifically to GHRH receptors on the anterior pituitary gland, stimulating the production and secretion of Growth Hormone.

2. Albumin Binding (DAC Effect): The Drug Affinity Complex covalently binds to circulating serum albumin, protecting the peptide from rapid enzymatic degradation.

3. Downstream IGF-1 Cascade: Sustained GH levels trigger hepatic production of IGF-1, mediating systemic anabolic and restorative effects across bone, muscle, and adipose tissues.